Deutsches Arzteblatt International is a premier journal in the field of medicine, published by DEUTSCHER AERZTE-VERLAG GMBH and based in Germany. This journal serves as a vital platform for the dissemination of high-quality research and clinical advancements, contributing significantly to the medical community's understanding of various health-related issues. With an impressive Scopus ranking placing it in the top 20% of general medicine journals (Rank #129/636, 79th percentile), it is recognized for its rigorous peer-reviewed articles that cover a diverse range of topics in compartmentalized medicine. This publication is available in both print and digital formats, and though it currently does not utilize an Open Access model, its growing recognition in the scientific community, indicated by its Q3 quartile rating and its active publication cycle from 2009 to 2024, makes it an essential resource for researchers, clinicians, and students seeking to stay informed on the latest developments in the field.

TERAPEVTICHESKII ARKHIV, published by CJSC CONSILIUM MEDICUM, is a distinguished open-access journal that has been pivotal in the fields of Endocrinology, Family Practice, History, and Internal Medicine since its inception in 1949. Recognized in 2023 with quartile rankings of Q3 in Family Practice and notable placements in other categories, the journal aims to disseminate high-quality research, innovative treatment methods, and comprehensive reviews that advance the understanding of medical practices and historical contexts within these disciplines. With its commitment to accessibility, as demonstrated by its open-access policy initiated in 2018, TERAPEVTICHESKII ARKHIV serves as an invaluable resource for researchers, healthcare professionals, and students looking to stay abreast of cutting-edge advances and historical perspectives in medicine, especially within the Russian Federation. The journal’s focus on interdisciplinary approaches encourages a rich dialogue across various medical fields, underlining its significance in fostering a well-rounded academic community.

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

The Lancet Regional Health-Europe is a prestigious academic journal published by Elsevier, dedicated to advancing research in the fields of Health Policy, Internal Medicine, and Oncology. As part of a reputable series that focuses on regional health issues, it aims to publish high-quality, peer-reviewed articles that contribute to the understanding and improvement of health systems across Europe. With an impressive impact factor reflected in its Q1 quartile rankings for 2023—ranking #2 in Health Policy, #8 in Internal Medicine, and #22 in Oncology—it is recognized for its significant contribution to cutting-edge research. The journal offers open access options, ensuring that findings are widely disseminated and accessible to researchers, healthcare professionals, and policy-makers alike. By fostering collaboration and interdisciplinary discourse, The Lancet Regional Health-Europe serves as an essential platform for innovative solutions and strategies in health care that address the unique challenges faced within the European context, making it an invaluable resource for academics and practitioners dedicated to public health advancement.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

JOURNAL OF GENERAL INTERNAL MEDICINE, a leading publication in the field of internal medicine, is published by Springer and boasts an impressive Q1 rank in internal medicine as of 2023, situating itself prominently at Rank #28 out of 167 in Scopus with an 83rd percentile. Since its inception in 1986, this esteemed journal has been at the forefront of disseminating high-quality research, clinical practices, and healthcare innovations that shape the landscape of internal medicine. The journal is recognized for its original research, systematic reviews, and practice guidelines that are essential for professionals navigating the complexities of patient care and clinical decision-making. With access options available, it serves as a critical resource for researchers, healthcare practitioners, and students alike, facilitating the enhancement of medical knowledge and evidence-based practice globally. The Journal's commitment to excellence is reflected in its ongoing contribution to advancing the field and ensuring that the latest findings reach those who need them most.

CLINICAL MEDICINE is a distinguished academic journal dedicated to advancing the field of medicine, published by the Royal College of Physicians of London. Operating since 1973, it has established itself as a critical platform for disseminating innovative research and insights in the realm of clinical practice. With an impressive impact factor positioning it in the Q2 category within the broad spectrum of Medicine (miscellaneous) and ranking 56th out of 636 in General Medicine according to Scopus, the journal is a vital resource for researchers, practitioners, and students alike. CLINICAL MEDICINE provides open access options, ensuring that its findings are widely accessible to the global medical community, fostering collaboration and knowledge sharing. As the field of medicine continues to evolve, this journal remains committed to enhancing clinical practices through rigorous research, critical reviews, and comprehensive articles that examine contemporary challenges and breakthroughs in medicine.

REVISTA CLINICA ESPANOLA, a leading journal in the field of general medicine, has been a pivotal platform for disseminating clinical research and advancements since its inception in 1947. Published by EDICIONES DOYMA S A in Barcelona, Spain, this journal plays a significant role in enhancing medical practice and research, as evidenced by its impressive Scopus ranking of #116 out of 636 in the field, placing it in the 81st percentile. Although it currently does not offer open access options, the journal continues to attract high-quality submissions focused on diverse medical topics, making it an essential resource for health professionals, researchers, and students alike. With a current categorization of Q3 in Medicine (miscellaneous), REVISTA CLINICA ESPANOLA remains committed to bridging the gap between clinical practice and research, thereby contributing to the overall improvement of healthcare outcomes.

The JOURNAL OF INTERNAL MEDICINE, a prestigious publication in the field of Internal Medicine, is published by WILEY and ranks among the top journals in its category, holding a remarkable Q1 designation in the 2023 Scopus Rankings. With its ISSN 0954-6820 and E-ISSN 1365-2796, this journal has garnered a significant impact within the medical community, being ranked 7th out of 167 in the field and maintaining a remarkable 96th percentile ranking. The journal covers a broad spectrum of research topics relevant to internal medicine, providing vital insights that advance clinical practices and enhance patient care. Since its inception in 1989, the JOURNAL OF INTERNAL MEDICINE has established itself as an essential resource for researchers, healthcare professionals, and students, facilitating the dissemination of groundbreaking studies and fostering academic discourse. Despite its traditional access model, the journal's commitment to high-quality research remains unwavering, making it a cornerstone in the field of Internal Medicine.

JOURNAL OF HUMAN HYPERTENSION, a prominent publication in the field of internal medicine, is dedicated to advancing the understanding of hypertension and its implications for human health. Published by SPRINGERNATURE in the United Kingdom, this esteemed journal has been a vital resource for researchers and clinicians since its inception in 1987, with a continuous commitment to disseminating high-quality, peer-reviewed research. With an impressive Q2 category rank in Internal Medicine and a Scopus rank of 53 out of 167, it occupies a crucial position within the academic community, reaching a 68th percentile ranking that underscores its significance. The journal aims to provide a platform for innovative studies and reviews, fostering knowledge that bridges basic science, clinical practice, and public health. Although it does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital information about hypertension is available to a broad spectrum of healthcare professionals and researchers. Explore the critical findings and groundbreaking research published in the JOURNAL OF HUMAN HYPERTENSION to stay at the forefront of hypertension studies.